Research
Metabolic adaptation
Metformin has the most evidence to support its use in targeting antipsychotic-induced weight gain.
Metformin should be considered as a treatment option for managing weight gain in these patients.
StrongSupportsmedium confidence
Among current approaches to target AIWG, metformin has the most evidence to support its use.
Why this rating
The review indicates a strong basis for metformin's use in this context.
Source
Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations
Nicolette Stogios et al. · Current Psychiatry Reports · 2023
reviewCited 52×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →